Nuclear Medicine
DOPA
Name:
Dopapet Radiofarma
Active Principle:
18 Fluordopa
Therapeutic Action:
In Neurology it is indicated to evaluate the state of the striatum in patients with altered motor signs and to detect the loss of functional dopaminergic nerve endings. They allow to differentiate Idiopathic Parkinsonism from the so-called pseudo-parkinsonisms, such as Essential Tremor (ET) and Vascular Parkinsonism (Arteriosclerotic). In Oncology it is indicated to diagnose and locate insulinomas in infants and children, gliomic tumors, pheochromocytomas, paragangliomas and medullary thyroid carcinoma.
Nuclear Medicine
DOPA
Name:
Dopapet Radiofarma
Active Principle:
18 Fluordopa
Therapeutic Action:
In Neurology it is indicated to evaluate the state of the striatum in patients with altered motor signs and to detect the loss of functional dopaminergic nerve endings. They allow to differentiate Idiopathic Parkinsonism from the so-called pseudo-parkinsonisms, such as Essential Tremor (ET) and Vascular Parkinsonism (Arteriosclerotic). In Oncology it is indicated to diagnose and locate insulinomas in infants and children, gliomic tumors, pheochromocytomas, paragangliomas and medullary thyroid carcinoma.
RELATED PRODUCTS
-
PARTITION FLASK
PARTITION FLASKVial containing a mixture of solvents to carry out a chromatographic separation ... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness...

